Phase 1b Study Of Bxcl701, A Novel Small Molecule Inhibitor Of Dipeptidyl Peptidases (Dpp), Combined With Pembrolizumab (Pembro), In Men With Metastatic Castration-Resistant Prostate Cancer (Mcrpc).
JOURNAL OF CLINICAL ONCOLOGY(2020)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要